We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
+31.33%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$2.21B
AUM Growth
+$361M
Cap. Flow
-$44.8M
Cap. Flow %
-2.03%
Top 10 Hldgs %
47.06%
Holding
101
New
14
Increased
23
Reduced
22
Closed
13

Top Buys

Rank Stock Value
1
RARE icon
Ultragenyx Pharmaceutical
RARE
+$56.1M
2
TSM icon
TSMC
TSM
+$37M
3
GS icon
Goldman Sachs
GS
+$36.8M
4
APO icon
Apollo Global Management
APO
+$30.8M
5
FERG icon
Ferguson
FERG
+$29.7M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$91M
2
AMD icon
Advanced Micro Devices
AMD
+$42.8M
3
WYNN icon
Wynn Resorts
WYNN
+$42.5M
4
NVDA icon
NVIDIA
NVDA
+$38.5M
5
AMZN icon
Amazon
AMZN
+$35.2M

Sector Composition

Rank Sector Weight
1 Healthcare 67.65%
2 Technology 8.34%
3 Consumer Discretionary 5.97%
4 Communication Services 5.67%
5 Industrials 4.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCK icon
26
McKesson
MCK
$101B
$29.4M 1.33%
63,460
+25,920
+69% +$11.8M
CI icon
27
Cigna
CI
$74.6B
$28.8M 1.3%
96,300
+92,300
+2,308% +$27M
ARQT icon
28
Arcutis Biotherapeutics
ARQT
$3.18B
$27.4M 1.24%
8,473,101
+7,337,874
+646% +$19.9M
VZ icon
29
Verizon
VZ
$196B
$27M 1.22%
+716,850
New +$25.4M
ELV icon
30
Elevance Health
ELV
$85.5B
$25.3M 1.15%
53,735
+50,725
+1,685% +$23.5M
STRO icon
31
Sutro Biopharma
STRO
$421M
$24.8M 1.12%
577,819
-10,550
-2% -$335K
KWEB icon
32
CALL
KraneShares CSI China Internet ETF
KWEB
$5.67B
$24.3M 1.1%
+900,000
New +$24.4M
COGT icon
33
Cogent Biosciences
COGT
$7.24B
$21.8M 0.99%
3,710,539
+657,239
+22% +$5.04M
T icon
34
AT&T
T
$163B
$20.5M 0.93%
+1,220,080
New +$19.3M
ARGX icon
35
argenx
ARGX
$54.1B
$20.4M 0.92%
53,700
+50,900
+1,818% +$23.7M
CMG icon
36
Chipotle Mexican Grill
CMG
$41.5B
$19.9M 0.9%
435,500
-584,500
-57% -$24.3M
HLT icon
37
Hilton Worldwide
HLT
$71.5B
$19.9M 0.9%
109,262
-4,700
-4% -$767K
RCUS icon
38
Arcus Biosciences
RCUS
$3.64B
$18.3M 0.83%
957,304
+360,205
+60% +$5.76M
MREO
39
Mereo BioPharma
MREO
$47.3M
$17M 0.77%
7,370,838
+6,400
+0.1% +$12.2K
BCYC
40
Bicycle Therapeutics
BCYC
$292M
$16.5M 0.75%
914,476
-96,500
-10% -$1.6M
GPN icon
41
Global Payments
GPN
$22.8B
$14.3M 0.65%
112,380
-172,108
-60% -$19.9M
JNJ icon
42
Johnson & Johnson
JNJ
$625B
$14.1M 0.64%
90,097
– –
ZURA icon
43
Zura Bio
ZURA
$566M
$13.3M 0.6%
2,850,000
– –
IFRX icon
44
InflaRx
IFRX
$271M
$9.35M 0.42%
5,733,910
– –
ELAN icon
45
Elanco Animal Health
ELAN
$11.1B
$9.15M 0.41%
614,300
+77,800
+15% +$881K
AGIO icon
46
Agios Pharmaceuticals
AGIO
$1.93B
$8.9M 0.4%
399,451
-54,549
-12% -$1.22M
SNY icon
47
Sanofi
SNY
$104B
$8.5M 0.38%
171,001
+54,960
+47% +$2.69M
ANAB icon
48
AnaptysBio
ANAB
$1.68B
$7.6M 0.34%
354,872
-124,573
-26% -$2.15M
PROK icon
49
ProKidney
PROK
$337M
$6.88M 0.31%
3,867,847
+4
+0% +$9
KZR
50
DELISTED
Kezar Life Sciences
KZR
$6.79M 0.31%
716,759
– –
1
2
3 4 5

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Suvretta Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Suvretta Capital Management held 101 positions worth $2.21B, up 20% from $1.85B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Suvretta Capital Management's Q4 2023 filing shows 14 new, 23 increased, 22 reduced and 13 closed positions. Its largest new stake was TSMC: 388,232 shares worth $40.4M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $91M.

By sector, the portfolio is most concentrated in Healthcare at 68% of assets, up from 63% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Suvretta Capital Management's largest Q4 2023 buy was TSMC: 388,232 shares worth $40.4M.
  • Suvretta Capital Management added most to Ultragenyx Pharmaceutical in Q4 2023, an estimated $56.1M increase.
  • Suvretta Capital Management's biggest Q4 2023 reduction was Advanced Micro Devices, cutting an estimated $42.8M.
  • Suvretta Capital Management fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $91M.
  • Suvretta Capital Management's ten largest holdings make up 47% of its $2.21B portfolio in Q4 2023.
  • Suvretta Capital Management opened 14 new positions and closed 13 in Q4 2023.
  • Suvretta Capital Management's portfolio value rose 20% quarter-over-quarter to $2.21B.

Based on Suvretta Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.